A randomized, double-blind, placebo-controlled, ascending, single-dose study of a human monoclonal anti-FGF23 antibody (KRN23) in X-linked hypophosphatemia

Autor:	Tetsuyoshi Kawakami, Thomas O. Carpenter, Mary D. Ruppe, Munro Peacock, Thomas Weber, Xiaoping Zhang, Karl L. Insogna, Mark A. Klausner, Margaret M. Wooddell, Takahiro Ito, Erik A. Imel, Jeffrey Humphrey
Rok vydání:	2014
Předmět:	medicine.medical_specialty biology business.industry General Medicine Placebo X-linked hypophosphatemia medicine.disease Gastroenterology Double blind Internal medicine Monoclonal medicine biology.protein Antibody business
Zdroj:	Bone Abstracts.
ISSN:	2052-1219
DOI:	10.1530/boneabs.3.pp90
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9fce4c3866f02305983fcd26e59b67ef https://doi.org/10.1530/boneabs.3.pp90 Zobrazit plný text záznamu